Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients

Joost H van Ginkel, Manon M H Huibers, Robert J J van Es, Remco de Bree, Stefan M Willems

Research output: Contribution to journalArticleAcademicpeer-review

1 Downloads (Pure)

Abstract

BACKGROUND: During posttreatment surveillance of head and neck cancer patients, imaging is insufficiently accurate for the early detection of relapsing disease. Free circulating tumor DNA (ctDNA) may serve as a novel biomarker for monitoring tumor burden during posttreatment surveillance of these patients. In this exploratory study, we investigated whether low level ctDNA in plasma of head and neck cancer patients can be detected using Droplet Digital PCR (ddPCR).

METHODS: TP53 mutations were determined in surgically resected primary tumor samples from six patients with high stage (II-IV), moderate to poorly differentiated head and neck squamous cell carcinoma (HNSCC). Subsequently, mutation specific ddPCR assays were designed. Pretreatment plasma samples from these patients were examined on the presence of ctDNA by ddPCR using the mutation-specific assays. The ddPCR results were evaluated alongside clinicopathological data.

RESULTS: In all cases, plasma samples were found positive for targeted TP53 mutations in varying degrees (absolute quantification of 2.2-422 mutational copies/ml plasma). Mutations were detected in wild-type TP53 background templates of 7667-156,667 copies/ml plasma, yielding fractional abundances of down to 0.01%.

CONCLUSIONS: Our results show that detection of tumor specific TP53 mutations in low level ctDNA from HNSCC patients using ddPCR is technically feasible and provide ground for future research on ctDNA quantification for the use of diagnostic biomarkers in the posttreatment surveillance of HNSCC patients.

Original languageEnglish
Article number428
JournalBMC Cancer
Volume17
Issue number1
DOIs
Publication statusPublished - 19 Jun 2017

Keywords

  • Circulating tumor DNA
  • Diagnostic biomarker
  • Droplet digital PCR
  • Head and neck cancer
  • TP53 mutations

Fingerprint

Dive into the research topics of 'Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients'. Together they form a unique fingerprint.

Cite this